切换至 "中华医学电子期刊资源库"
高级检索
中华疝和腹壁外科杂志(电子版)

中华疝和腹壁外科杂志(电子版) ›› 2020, Vol. 14 ›› Issue (05) : 516 -520. doi: 10.3877/cma.j.issn.1674-392X.2020.05.013

所属专题： 文献；

临床论著

直肠癌患者Miles术后发生造口旁疝的影响因素分析
俞士卉1, 苏丽华1, 熊茂明1, 张倩倩1,†()   
  1. 1. 230022　合肥，安徽医科大学第一附属医院胃肠外科
  • 收稿日期:2019-08-02 出版日期:2020-10-20
  • 通信作者: 张倩倩
  • 基金资助:
    吴阶平医学基金会临床科研专项(No: 320 6750 15235)

Analysis of influence factors for the development of parastomal hernia in rectal cancer patients after Miles operation

Shihui Yu1, Lihua Su1, Maoming Xiong1, Qianqian Zhang1,†()   

  1. 1. Department of Gastrointestinal Surgery, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
  • Received:2019-08-02 Published:2020-10-20
  • Corresponding author: Qianqian Zhang
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

俞士卉, 苏丽华, 熊茂明, 张倩倩. 直肠癌患者Miles术后发生造口旁疝的影响因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2020, 14(05): 516-520.

Shihui Yu, Lihua Su, Maoming Xiong, Qianqian Zhang. Analysis of influence factors for the development of parastomal hernia in rectal cancer patients after Miles operation[J/OL]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2020, 14(05): 516-520.

目的

探索直肠癌患者Miles术后发生造口旁疝的相关影响因素。

方法

回顾性调查分析2016年1月至2019年1月在安徽医科大学第一附属医院胃肠外科行Miles术的84例直肠癌患者的病案资料，采用单因素分析和二分类Logistic回归分析发生造口旁疝的相关影响因素。

结果

84例患者中，有16例患者在随访期间发生了造口旁疝，发生率为19%。单因素分析显示：造口旁疝组和非造口旁疝组患者组间的体质量指数（BMI）、甲胎蛋白水平比较，差异有统计学意义（P<0.05）；2组患者组间的有无疾病合并症、Tumor分期及术后有无发生低蛋白血症比较，差异均接近显著性水平（0.05<P<0.1）。二分类Logistic回归分析显示：BMI（>25 kg/m2）是发生造口旁疝的重要影响因素[OR=6.784，β=1.915，95% CI（1.979～23.263），P=0.002]；此外，术后低蛋白血症是发生造口旁疝的可能影响因素[OR=3.501，β=1.253，95% CI（0.989～12.388），P=0.052]。

结论

对于超重肥胖患者（BMI>25 kg/m2）在术前应合理控制体重，与此同时，针对术后发生营养风险的患者应积极改善营养状况，从而以降低造口旁疝的发生风险。

关键词: 造口旁疝, 直肠肿瘤, Miles术, 影响因素
Objective

To explore the influence factors for the development of parastomal hernia in rectal cancer patients after Miles operation.

Methods

In a retrospective study, the clinical data of 84 rectal cancer patients who underwent Miles operation at the department of gastrointestinal surgery of the First Affiliated Hospital of Anhui Medical University between January 2016 and January 2019 were analyzed. The univariate analysis and binary logistic regression analysis were used to analyze relevant influence factors for the development of parastomal hernia.

Results

Of 84 patients, 16 patients occurred parastomal hernia during the follow-up period, and the incidence of parastomal hernia was 19%. The univariate analysis showed that there were statistically significant differences in BMI and alpha-fetoprotein levels between parastomal hernia group and the non-parastomtal hernia group (P<0.05). Besides, the differences in comorbidities of disease, tumor stage and postoperative hypoalbuminemia between the two groups of subjects were very close to a significant level (0.05<P<0.1). The binary logistic regression analysis showed that BMI (>25 kg/m2) was significantly related to the development of parastomtal hernia [OR=6.784, β=1.915, 95% CI (1.979-23.263), P=0.002]; in addition, a postoperative hypoalbuminemia may be a potential factor for the development of parastomtal hernia [OR=3.501, β=1.253, 95% CI (0.989-12.388), P=0.052].

Conclusion

For overweight and obese patients (BMI>25 kg/m2), whose preoperative weight should be controlled reasonably; meanwhile, the nutritional status of patients at postoperative nutritional risk should be improved actively to avoid the development of parastomtal hernia.

Key words: Parastomtal hernia, Miles operation, Rectal neoplasms, Influence factors
表1 2组一般临床资料比较[例(%)]
临床资料 造口旁疝组(16例) 非造口旁疝组(68例) χ2值 P值
性别(男/女) 7(43.8)/9(56.3) 39(57.4)/29(42.6) 0.967 0.325
年龄(≤65/>65岁) 8(50.0)/8(50.0) 38(55.9)/30(44.1) 0.181 0.671
BMI(≤25/>25 kg/m2) 7(43.8)/9(56.3)* 56(82.4)/12(17.6) _‡ 0.003
吸烟(否/是) 11(68.8)/5(31.3) 42(61.8)/26(38.2) 0.271 0.602
饮酒(否/是) 11(68.8)/5(31.3) 47(69.1)/21(30.9) _‡ 1.000
外科手术史(否/是) 14(87.5)/2(12.5) 56(82.4)/12(17.6) _‡ 1.000
术前化疗(否/是) 0(0)/16(100.0) 4(5.9)/64(94.1) _‡ 1.000
术前使用抗生素(否/是) 5(31.3)/11(68.8) 15(22.1)/53(77.9) _‡ 1.000
疾病合并症(否/是) 5(31.3)/11(68.8)† 37(54.4)/31(45.6) 2.779 0.095
T     6.106‡ 0.083
  1 2(12.5)† 10(14.7)    
  2 8(50.0)† 17(25.0)
  3 3(18.8)† 8(11.8)
  4 3(18.8)† 33(48.5)
N     2.887‡ 0.248
  0 14(87.5) 43(63.2)    
  1 1(6.3) 12(17.6)
  2 1(6.3) 13(19.1)
M     _‡ 1.000
  0 16(100.0) 67(98.5)    
  1 0(0) 1(1.5)
ASA分级     3.083‡ 0.161
  Ⅰ 1(6.3) 6(8.8)    
  Ⅱ 11(68.8) 56(82.4)
  Ⅲ 4(25.0) 6(8.8)
手术方式(开腹/腹腔镜) 1(6.3)/15(93.8) 7(10.3)/61(89.7) _‡ 1.000
手术时间(≤4 h/>4 h) 9(56.3)/7(43.8) 40(58.8)/28(41.2) 0.035 0.851
手术当天至出院时间(≤10 d/>10 d) 6(37.5)/10(62.5) 37(54.4)/31(45.6) 1.483 0.223
造口排气时间(≤3 d/>3 d) 10(62.5)/6(37.5) 48(70.6)/20(29.4) _‡ 0.557
术后输血(否/是) 15(93.8)/1(6.3) 62(91.2)/6(8.8) _‡ 1.000
术后低蛋白血症(否/是) 5(31.3)/11(68.8)† 39(57.4)/29(42.6) 3.538 0.060
表2 2组实验室指标比较
实验室指标 造口旁疝组(16例) 非造口旁疝组(68例) t/Z值 P值
红细胞(^1012/L) 4.35±0.40 4.46±0.46 0.906 0.368
白细胞(10-9/L) 5.71(4.95~6.85) 5.55(4.62~6.63) -0.587 0.557
血红蛋白(g/L) 129.50(121.00~134.00) 131.00(120.00~143.00) -0.633 0.527
前白蛋白(mg/L) 261.19±49.82 244.51±56.45 -1.085 0.281
白蛋白(g/L) 43.08±3.78 43.71±3.29 0.672 0.503
总蛋白(g/L) 65.80(65.05~74.48) 69.95(66.80~73.48) -1.316 0.188
甲胎蛋白(ng/ml) 2.24(1.33~3.00)* 3.03(1.89~3.97) -2.074 0.038
癌胚抗原(ng/ml) 3.05(1.36~12.82) 3.90(2.12~6.45) -0.678 0.498
糖链抗原125(U/ml) 10.66(6.30~12.14) 10.39(7.46~13.49) -0.308 0.758
糖链抗原19-9(U/ml) 8.72(6.92·16.43) 14.83(7.57~20.69) -1.453 0.146
肿瘤体积(cm3) 10.13(6.02~26.25) 14.51(7.49~22.30) -0.046 0.964
表3 变量赋值说明
变量 赋值说明
性别 女性=0,男性=1
年龄 ≤65岁=0,>65岁=1
BMI ≤25 kg/m2=0,>25 kg/m2=1
吸烟 否=0,是=1
饮酒 否=0,是=1
外科手术史 否=0,是=1
术前化疗 否=0,是=1
术前使用抗生素 否=0,是=1
疾病合并症 否=0,是=1
T T1=1,T2=2,T3=3,T4=4
N N0=0,N1=1,N2=2
M M0=0,M1=1
ASA分级 ASAI=1,ASAII=2,ASAIII=3
手术方式 腹腔镜=0,开腹=1
手术时间 ≤4 h=0,>4 h=1
手术当天至出院时间 ≤10 d=0,>10 d=1
造口排气时间 ≤3 d=0,>3 d=1
术后输血 否=0,是=1
术后低蛋白血症 否=0,是=1
造口旁疝 否=0,是=1
表4 发生造口旁疝影响因素的Logistic回归分析
指标 β SE OR 95% CI P值
常数 -2.826 0.613 0.059 - <0.001
BMI 1.915 0.629 6.784 1.979-23.263 0.002
术后低蛋白血症 1.253 0.645 3.501 0.989-12.388 0.052
[1]
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
[2]
郁宝铭. 当前对低位直肠癌的治疗对策[J]. 中华胃肠外科杂志, 2004, 7(2): 87-89.
[3]
周总光，王自强. 欧美与日本中低位直肠癌诊治指南解读[J]. 中国实用外科杂志, 2009, 29(4): 291-292.
[4]
顾纪明，蒋晖，金留根, 等. 改良腹腔镜下Miles术切除肛管直肠环方法治疗低位直肠癌的应用体会[J]. 结直肠肛门外科, 2019, 25(6): 674-677.
[5]
Vierimaa M, Klintrup K, Biancari F, et al. Prospective, randomized study on the use of a prosthetic mesh for prevention of parastomal hernia of permanent colostomy[J]. Dis Colon Rectum, 2015, 58(10): 943-949.
[6]
Canda AE, Terzi C, Agalar C, et al. Preventing parastomal hernia with modified stapled mesh stoma reinforcement technique(SMART) in patients who underwent surgery for rectal cancer: a case-control study[J]. Hernia, 2018, 22(2): 379-384.
[7]
Chapman SJ, Wood B, Drake TM, et al. Systematic review and meta-analysis of prophylactic mesh during primary stoma formation to prevent parastomal hernia[J]. Dis Colon Rectum, 2017, 60(1): 107-115.
[8]
Muysoms F, Campanelli G, Champault GG, et al. EuraHS: the development of an international online platform for registration and outcome measurement of ventral abdominal wall hernia repair[J]. Hernia, 2012, 16(3): 239-250.
[9]
陈道瑾，代文杰. 造口旁疝的处理[J]. 中国现代手术学杂志, 2006, 10(4): 242-245.
[10]
陈富强，陈杰，申英末. 造口旁疝的诊疗现状及展望[J/OL]. 中华疝和腹壁外科杂志(电子版), 2014, 8(5): 470-472.
[11]
McGrath A, Porrett T, Heyman B. Parastomal hernia: an exploration of the risk factors and the implications[J]. Br J Nurs, 2006, 15(6): 317-321.
[12]
Mylonakis E, Scarpa M, Barollo M, et al. Life table analysis of hernia following end colostomy construction[J]. Colorectal Dis, 2001, 3(5): 334-337.
[13]
Krishnamurty DM, Blatnik J, Mutch M. Stoma complications[J]. Clin Colon Rectal Surg, 2017, 30(3): 193-200.
[14]
Carne PW, Robertson GM, Frizelle FA. Parastomal hernia[J]. Br J Surg, 2003, 90(7): 784-793.
[15]
Donahue TF, Bochner BH, Sfakianos JP, et al. Risk factors for the development of parastomal hernia after radical cystectomy[J]. J Urol, 2014, 191(6): 1708-1713.
[16]
Temple B, Farley T, Popik K, et al. Prevalence of parastomal hernia and factors associated with its development[J]. J Wound Ostomy Continence Nurs,2016, 43(5): 489-493.
[17]
Pilgrim C, McIntyre R, Bailey M. Prospective audit of parastomal hernia: prevalence and associated comorbidities[J]. Dis Colon Rectum, 2010, 53(1): 71-76.
[18]
Hotouras A, Murphy J, Thaha M, et al. The persistent challenge of parastomal herniation: a review of the literature and future developments[J]. Colorectal Dis, 2013, 15(5): e202-e214.
[19]
Arumugam PJ, Bevan L, Macdonald L, et al. A prospective audit of stomas-analysis of risk factors and complications and their management[J]. Colorectal Dis, 2003, 5(1): 49-52.
[20]
Smietanski M, Szczepkowski M, Alexandre JA, et al. European Hernia Society classification of parastomal hernias[J]. Hernia, 2014, 18(1): 1-6.
[21]
朱乐乐，王飞通，刘星, 等. 腹会阴联合直肠癌根治术后发生造口旁疝的影响因素[J]. 中国普外基础与临床杂志, 2018, 25(8): 964-969.
[22]
Ripoche J, Basurko C, Fabbro-Perray P, et al. Parastomal hernia. A study of the French federation of ostomy patients[J]. J Visc Surg, 2011, 148(6): e435-e441.
[23]
Glasgow SC, Dharmarajan S. Parastomal hernia: avoidance and treatment in the 21st Century[J]. Clin Colon Rectal Surg, 2016, 29(3): 277-284.
[24]
Aquina CT, Iannuzzi JC, Probst CP, et al. Parastomal hernia: a growing problem with new solutions[J]. Dig Surg, 2014, 31(4/5): 366-376.
[25]
Antoniou SA, Agresta F, Garcia Alamino JM, et al. European Hernia Society guidelines on prevention and treatment of parastomal hernias[J]. Hernia, 2018, 22(1): 183-198.
[26]
Sohn YJ, Moon SM, Shin US, et al. Incidence and risk factors of parastomal hernia[J]. J Korean Soc Coloproctol, 2012, 28(5): 241-246.
[27]
Kojima K, Nakamura T, Sato T, et al. Risk factors for parastomal hernia after abdominoperineal resection for rectal cancer[J]. Asian J Endosc Surg, 2017, 10(3): 276-281.
[28]
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies[J]. Lancet, 2004, 363(9403): 157-163.
[29]
戴利. 身体质量指数对肠造口并发症的影响浅析[J]. 结直肠肛门外科, 2019, 25(5): 626-628.
[30]
王灵，张曲娣. 普通外科手术切口感染的多因素分析[J]. 实用医药杂志, 2007, 24(5): 521-523.
[31]
Shellito PC. Complications of abdominal stoma surgery[J]. Dis Colon Rectum, 1998, 41(12): 1562-1572.
[32]
de Raet J, Delvaux G, Haentjens P, et al. Waist circumference is an independent risk factor for the development of parastomal hernia after permanent colostomy[J]. Dis Colon Rectum, 2008, 51(12): 1806-1809.
[33]
de Ruiter P, Bijnen AB. Successful local repair of paracolostomy hernia with a newly developed prosthetic device[J]. Int J Colorectal Dis, 1992, 7(3): 132-134.
[34]
Etherington RJ, Williams JG, Hayward MW, et al. Demonstration of para-ileostomy herniation using computed tomography[J]. Clin Radiol, 1990, 41(5): 333-336.
[35]
Clark LN, Helm MC, Higgins R, et al. The impact of preoperative anemia and malnutrition on outcomes in paraesophageal hernia repair[J]. Surg Endosc, 2018, 32(11): 4666-4672.
[36]
李基业. 造口旁疝的预防和处理[J]. 中国实用外科杂志, 2012, 32(1): 66-69.
[37]
李洪超. 康复新液促进高位肛周脓肿术后创面愈合的临床研究[D].石家庄 :河北医科大学, 2014.
[38]
姚国良. 影响胶原代谢的因素与切口疝的关系[J]. 中华疝和腹壁外科杂志(电子版),2007, 1(1): 50-52.
[39]
Kroese LF, de Smet GHJ, Jeekel J, et al. Systematic review and Meta-analysis of extraperitoneal versus transperitoneal colostomy for preventing parastomal hernia[J]. Diseases of the Colon & Rectum, 2016, 59(7): 688-695.
[40]
Hardt J, Meerpohl JJ, Metzendorf MI, et al. Lateral pararectal versus transrectal stoma placement for prevention of parastomal herniation[J]. Cochrane Database Syst Rev, 2019, 4(4): CD009487.
[41]
Jones HG, Rees M, Aboumarzouk OM, et al. Prosthetic mesh placement for the prevention of parastomal herniation[J]. Cochrane Database Syst Rev,2018, 7(7): CD008905.
[42]
Blake PA, Williams GL, Stephenson BM. Prophylactic mesh to prevent parastomal hernia: further questions need answering[J]. Tech Coloproctol, 2017, 21(6): 481.
[1] 王振宁, 杨康, 王得晨, 邹敏, 归明彬, 王雅楠, 徐明. 机器人与腹腔镜手术联合经自然腔道取标本对中低位直肠癌患者远期疗效比较[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 437-442.
[2] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[3] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[4] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[5] 奚玲, 仝瀚文, 缪骥, 毛永欢, 沈晓菲, 杜峻峰, 刘晔. 基于肌少症构建的造口旁疝危险因素预测模型[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 48-51.
[6] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[7] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[8] 张超, 张珍, 马梁, 穆欢欢, 刘彩玲. 腹腔镜胰十二指肠切除术术后C级胰瘘患者临床特征及影响因素研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 675-678.
[9] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[10] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[11] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[12] 陈杰, 武明胜, 李一金, 李虎, 向源楚, 荣新奇, 彭健. 低位直肠癌冷冻治疗临床初步分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 494-498.
[13] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[14] 王灿, 樊昊, 张卫, 于冠宇. LARS 评分的研制回顾与应用现状[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 519-523.
[15] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号